Clinical Trials Logo
  1. Home
  2. Parkinson's Disease
  3. NCT00562198

PET-Study: Effects of Single Doses of Stalevo and Levodopa/Carbidopa on Striatal 11C-Raclopride Binding

Parkinson´s Disease Clinical Trial

Official title:
Effects of Single Doses of Stalevo 200 and Levodopa/Carbidopa 200/50mg on Striatal 11C-Raclopride Binding Potential in Parkinson's Disease Patients With Wearing-Off Symptoms;an Open, Randomised, Active-Controlled,Two-Period Crossover Study.

Clinical Trial Summary

This is an open, randomised, active-controlled, 2-period crossover study comparing the effect of single doses of Stalevo 200 and Sinemet on striatal (putamenal and caudate) 11C-raclopride BP in PD patients with wearing-off symptoms. The study consists of 4 visits: a screening visit (visit 1), 2 treatment periods (period 1=visit 2, period 2=visit 3) separated by a minimum wash-out period of at least 3 days, and an end-of-study visit (visit 4). Subjects will be randomly allocated to start the period 1 with a single dose of Stalevo 200 or Sinemet. After the wash-out the study drug on period 2 will be administered according to a crossover design.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT00562198
Study type Interventional
Source Orion Corporation, Orion Pharma
Contact
Status Terminated
Phase Phase 2
Start date January 2008
Completion date May 2008
View Details
See also
  Status Clinical Trial Phase
Completed NCT01736891 - Clinical Trial of Rasagiline in Levodopa-Treated Parkinson's Disease Patients With Motor Fluctuations Phase 3
Recruiting NCT03866603 - Rostock International Parkinson's Disease Study (ROPAD)
Completed NCT00902941 - Olfaction in Patients With Parkinson's Disease Following Treatment With Rasagiline Phase 4
Completed NCT03103919 - Study to Evaluate the Impact of Using Wearable Devices in Addition to Standard Clinical Practice on Parkinson´s Subject Symptoms Management Phase 4
Recruiting NCT01650623 - Gait Training With Executive Functions Tasks in Subjects With Parkinson´s Disease: A Randomised Controlled Trial N/A
Recruiting NCT01650610 - Gait Training With Executive Functions Tasks in Subjects With Parkinson´s Disease: A Study Protocol N/A
Recruiting NCT02578849 - Common Noradrenergic Mechanisms in Parkinson´s Disease and L-DOPA Induced Dyskinesia N/A
Completed NCT01003535 - Quantification of Cerebral Cholinergic Function in Parkinson´s Disease by Means of Nuclear Medicine Methods Phase 1
Completed NCT01038310 - Prognostic Value of FP-CIT-SPECT in Parkinson´s Disease
Completed NCT01580787 - Functional Improvement in Patients With Parkinson's Disease After Training in Real or Virtual Environment N/A
Completed NCT00964652 - Treadmill Training With Additional Body Load: Effects on Gait of Subjects With Parkinson´s Disease N/A
Completed NCT01960985 - Balance Training in Parkinson's Disease Using Cues Phase 3
Completed NCT01391741 - The Effect of High-Volume Walking With Visual Cues (VC) in Parkinson´s Disease (PD) Phase 3